Cargando…
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor
SIMPLE SUMMARY: Tumors in the pancreas and colon are still too often an unmet clinical problem. Cells from these cancers and normal cells have different gene expression profiles. Such dysregulation can be exploited with novel drugs that modulate the acetylation of proteins. We present KH16, a novel...
Autores principales: | Ashry, Ramy, Mustafa, Al-Hassan M., Hausmann, Kristin, Linnebacher, Michael, Strand, Susanne, Sippl, Wolfgang, Wirth, Matthias, Krämer, Oliver H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377841/ https://www.ncbi.nlm.nih.gov/pubmed/37509312 http://dx.doi.org/10.3390/cancers15143650 |
Ejemplares similares
-
Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3
por: Zeyn, Yanira, et al.
Publicado: (2023) -
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
por: Ghazy, Ehab, et al.
Publicado: (2022) -
Induction of Noxa-Mediated Apoptosis by Modified Vaccinia Virus Ankara Depends on Viral Recognition by Cytosolic Helicases, Leading to IRF-3/IFN-β-Dependent Induction of Pro-Apoptotic Noxa
por: Eitz Ferrer, Pedro, et al.
Publicado: (2011) -
Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70
por: Gong, Ping, et al.
Publicado: (2019) -
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
por: Vaca, Hugo Rolando, et al.
Publicado: (2021)